26-0103
Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Pasteur, Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services through September 30, 2026 with additional mutually agreed upon renewal option(s), using grant funds provided by the U.S. Department of Health and Human Services Refugee Medical Assistance Program.
What this record is
- Held by
- Merck & Co., Inc 4 records across this site
- Amount
- $1.60M
- Runs until
- September 30, 2026 30 days — goes back out to bid date quoted from the award document
- Type
- amendment
- Field
- Health & social
See everything else expiring in this field →
Read automatically from the title of the official record. The source document below is authoritative.
Merck & Co., Inc also holds
Request for approval of ratification of an amendment to a public health or safety exemption agreement with Merck & Co., Inc. d/b/a Merck Sharp & Dohme… Request by the Office of the Purchasing Agent for approval of a public health or safety exemption from the competitive bid requirements with Merck & C… Request by the Office of the Purchasing Agent for approval of a public health or safety exemption from the competitive bid requirements with Merck & C…- Committee
- Commissioners Court
- Requested by
- Purchasing
- Introduced
- December 17, 2025
- On agenda
- January 8, 2026
- Passed
- January 8, 2026